Severe cutaneous adverse reactions (SCAR) syndromes.
Patient Safety, AstraZeneca Research & Development, Parklands, Alderley Park, Macclesfield, Cheshire, UK. miriam.marotti@astrazeneca.com
Miriam
M
Marotti
D000208:Acute Disease; D003875:Drug Eruptions / Q000145:classification / Q000175:diagnosis* / Q000209:etiology; D006801:Humans; D012720:Severity of Illness Index